We have studied the nuclear localization of rhodamine-labeled pre-mRNA after microinjection into nuclei of cultured rat kidney epithelial cells. Intranuclear localization of the injected RNA was followed in the living cells by fluorescence microscopy and digital image processing. Injected human P-globin pre-mRNA became localized in 30-60 discrete nuclear sites that were coincident with li defined by monoclonal antibodies against small nuclear ribonudeoproteins (Sm) or another spliceosome component RNA and premRNA (5, 6) . snRNPs have also been shown to be colocalized with pre-mRNA transcripts on insect polytene chromosomes (7, 8) . However, the nuclear sites at which splicing actually takes place have not been defined. In the present investigation, our objective was to determine whether exogenous pre-mRNA has an affinity for a particular element of nuclear structure. We have developed a system in which rhodamine-labeled pre-mRNA is introduced into the nucleus of normal rat kidney (NRK) epithelial cells, and its intranuclear distribution is followed by fluorescence microscopy of the living cells.
Pre-messenger RNAs transcribed from intron-containing genes undergo splicing before exiting from the nucleus. Components of the splicing apparatus have recently been localized in discrete nuclear sites by immunocytochemistry of fixed mammalian somatic cells (1, 2) , and potentially analogous structures have been described in dispersed nuclei from amphibian oocytes (3, 4) . Immunocytochemical experiments at the electron microscopic level have revealed that the splicing-related small nuclear ribonucleoproteins (snRNPs) are associated with perichromatin fibrils, interchromatin granules, and coiled bodies, which are structures that are known to contain heterogeneous nuclear RNA and premRNA (5, 6) . snRNPs have also been shown to be colocalized with pre-mRNA transcripts on insect polytene chromosomes (7, 8) . However, the nuclear sites at which splicing actually takes place have not been defined.
In the present investigation, our objective was to determine whether exogenous pre-mRNA has an affinity for a particular element of nuclear structure. We have developed a system in which rhodamine-labeled pre-mRNA is introduced into the nucleus of normal rat kidney (NRK) epithelial cells, and its intranuclear distribution is followed by fluorescence microscopy of the living cells.
MATERIALS AND METHODS
Rhodamine Labeling of RNA. A human f-globin premRNA containing exon 1, intron 1, and 209 nucleotides of exon 2 (9) was transcribed from BamHI-cut plasmid SP64-H38A6 with SP6 RNA polymerase in the presence of 500 ,uM ATP, CTP, GTP, and UTP and 50 AM 5-(3-aminoallyl)-UTP (Sigma) (10) . The RNA was recovered by ethanol precipitation after phenol and chloroform extraction and was coupled to tetramethylrhodamine-6-isothiocyanate (Molecular Probes) as described (11) . The coupling reactions contained 25 mM sodium bicarbonate buffer (pH 9.0) and 16% (vol/vol) dimethylformamide. The rhodamine-RNA coupling reaction was carried out for 8-12 hr in the dark at 20'C in a tube mounted on a rocking platform. After the reaction, the RNA was purified by gel filtration through either Sephadex G-25 or Bio-Gel P-60 (with comparable results). RNA 2 until the maximal pixel value became <256 (and thus could be displayed as 8-bit images) and were then stored as computer files on a hard disk. Photographs were taken directly off the monitor screen using Kodak Tri-X film developed in Diafine (Acufine, Chicago).
Immunocytochemistry. Rhodamine-coupled pre-mRNA was injected into the nucleus as described above. After the desired period oftime, the cells were permeabilized and fixed (2) and then incubated with either Sm monoclonal antibody (16) After microinjection of =2000 molecules of rhodamineHfiA RNA into each nucleus of NRK epithelial cells, the intranuclear distribution was followed by fluorescence microscopy and digital image processing. Fig. 2 (Fig. 2 b-e) . The RNAs did not localize in nucleoli. Similar patterns of nuclear localization were observed after injection of a rhodamine-labeled rat proenkephalin premRNA (Fig. 2h) or an adenovirus pre-mRNA (data not shown).
Several control experiments demonstrated that the localization shown in Fig. 2 is specific for unspliced pre-mRNA. Injection of rhodamine-conjugated dextran (average Mr, 71,200) resulted in rapid dispersion throughout the nucleoplasm with no localization at discrete sites (Fig. 3 a and b) . Injection of rhodamine-labeled antisense (3-globin premRNA ( Fig. 3 c and d) or rhodamine-labeled (3-globin RNA containing exons 1 and 2, but lacking intron 1 (Fig. 3 e andf) also resulted in diffuse intranuclear patterns. Moreover, a rhodamine-labeled, splicing-defective mutant (-globin premRNA containing a deletion of the intron polypyrimidine tract and the 3' splice site did not accumulate in discrete loci (Fig. 3 g and h) .
Over the course ofmany injections of 3-globin pre-mRNA, %65% ofthe nuclei displayed the characteristic 30-60 sites of An antisense P-globin pre-mRNA (514 nucleotides long, essentially antisense to HPA; see ref. 19) , an intron-lacking P-globin RNA, and a mutant P-globin pre-mRNA lacking the polypyrimidine tract and 3' splice site were transcribed from the plasmids pT7HPA6 (19) , SP62 HP-IVS1,2 (20) , and APyAG (21) , respectively. Rhodamine labeling and microinjection were carried out as described in Fig. 1 localization. The remaining =35% of the injected nuclei displayed a diffuse pattern, although with a degree of localization in some cases. In contrast, in no case was localization observed with the splicing-defective control RNAs.
The typical pattern of nuclear pre-mRNA localization (Fig.  2) is very similar to previously reported patterns of immunoreactivity with spliceosome component antibodies (1, 2, 16, (22) (23) (24) . To determine whether these sites are one and the same, we injected rhodamine-labeled 3-globin pre-mRNA into the nucleus, allowed the RNA to localize, and then fixed the cell and carried out immunocytochemistry experiments with either Sm monoclonal antibody, which is specific for proteins common to several splicing-related snRNPs (16) , or a monoclonal antibody, a-SC-35, which is specific for a non-snRNP spliceosome (2) . As shown in Fig. 4 the same nuclei. Thus, living cells procure injected premRNA into nuclear sites that contain endogenous snRNPs and spliceosomal proteins. These results also demonstrate, importantly, that fixation and subsequent antibody staining do not alter the in vivo pattern of pre-mRNA localization.
We noted that the intensity of fluorescence at the discrete nuclear sites decreased 30 min postinjection. However, it is difficult to know whether this represents mRNA export. Since we inject =2000 molecules of pre-mRNA, the 30-60 sites of localization could each maximally contain 33-66 molecules. (It is to be emphasized that these sites cannot be seen in the fluorescence microscope with the unaided eye but require image intensification for visualization.) If some of the introduced nuclear RNA were exported or released to the cytoplasm during our typical 5-to 75-min period of observation, it would likely be below the detection threshold of our system.
In these experiments, we do not know whether the injected pre-mRNA undergoes splicing, either before or after its arrival at the observed sites of localization. However, the lack of localization observed with an intron-lacking 3-globin cDNA transcript and with a splicing-defective mutant premRNA demonstrates that intron sequences are required. Our results also demonstrate that a 3' poly(A) tail is not required for pre-mRNA localization at the observed sites. It is conceivable that our results are a visualization of active splicing centers, but there are other possibilities. For example, it is possible that endogenous pre-mRNA does not interact with these sites but that they nonetheless contain elements (e.g., snRNPs) that have affinity for the injected pre-mRNA. This scenario is rendered less likely by the coincidence of a non-snRNP splicing cofactor, SC-35 (2) , with these sites, but the possibility that the sites are regions at which splicing machinery is stored cannot be ruled out. Another possibility is that excised introns are shuttled to these sites, perhaps for debranching after the second step of splicing carried out elsewhere.
It has recently been reported that both U2 RNA and a U2 snRNP-associated factor, U2AF, are confined to one to five nuclear foci (25, 26) . It is possible that the nuclear localizations of U2 RNA or U2AF as compared to that of exogenous pre-mRNA or endogenous snRNPs or spliceosome proteins might reflect the restriction of different components of the splicing machinery to distinct spatial domains, depending on their use or storage. In any case, neither these experiments (25, 26) nor the present ones elucidate the nuclear sites of active mRNA splicing, and further studies are clearly required to resolve this important issue.
We note that several studies have shown that pre-mRNAs transcribed in vitro are spliced after injection into the nucleus of frog oocytes (27) (28) (29) (30) , demonstrating that transcription and splicing are not obligatorily coupled in this system. Comparable experiments injecting pre-mRNAs into somatic cell nuclei have not been reported, due mainly to the difficulty of injecting a sufficient number of cells to detect splicing of the recovered RNA. However, the fact that oligo(4T)-celluloseor poly(U)-Sepharose-selected nuclear RNA from vertebrate cells contains unspliced pre-mRNAs (refs. 31-33 and numerous subsequent studies) demonstrates that, at least for some transcripts, splicing occurs after poly(A) addition-i.e., after transcription. This consideration does not obviate the possibility that splicing also occurs on some nascent pre-mRNAs in vertebrate somatic cells, as has been visualized inDrosophila preblastoderm embryos (34, 35) . In any case, our results are compatible with these earlier findings in demonstrating that intranuclear movement of pre-mRNA to, and localization at, the observed nuclear sites is not obligatorily coupled to transcription. We suspect that in those cases in which splicing follows the completion of transcription, the premRNA may move only a short distance from its site of transcription before it associates with the first splicing center it encounters, a possibility compatible with previous results (1, 7) . The methods and results we have presented here open a potential path to resolving several aspects of RNA traffic in living cells. These include further definition of pre-iRNA sequences required for localization at these nuclear sites, the intranuclear localizations ofRNA polymerase III-transcribed RNA precursors, and the dynamics with which small nuclear RNA precursors exit the nucleus and return (36) (37) (38) 
